Your Expert Path from Idea to IND
Adracco supports small to mid-size radiopharmaceutical companies navigating the complex path from early idea to IND readiness.
What Adracco Does
Adracco provides direct access to world-class scientific expertise, specialized infrastructure, and practical development guidance.
With expert scientific leadership, specialized preclinical capabilities, and flexible engagement models, Adracco equips teams to understand what they have, what they need, and how to generate the right data to move forward with confidence.
The Right Science.
The Right Sequence.
The Right Support.
WHY ADRACCORadiopharmaceutical development requires more than access to equipment or isolated studies. It requires clear thinking around study design, development questions, sequencing, and data generation.
Adracco empowers teams to move faster and avoid unnecessary complexity by orienting each program around the right next step.
Direct access to experienced radiopharmaceutical development experts
Specialized preclinical infrastructure without unnecessary internal investment
Practical guidance for go/no-go decisions, investor conversations, and IND planning
Flexible support, from targeted studies to concept-to-IND guidance
Expert-led execution designed to answer the development questions that matter
WHO ADRACCO HELPSAdracco helps emerging teams turn early uncertainty into a practical preclinical development path, clarifying what studies matter first and what data is needed to move forward.
Startups & New Entrants
Adracco provides specialized infrastructure and expert execution to help development teams advance programs without adding unnecessary internal burden.
Medium-Sized Biotechs
Adracco offers the expert-led execution and specialized preclinical infrastructure needed to keep programs moving, with the scientific credibility and named expertise internal stakeholders and partners expect.